Here are some of the recent top stories on Healio.com/OSN: Xelpros gains FDA approval for open-angle glaucoma, ocular hypertensionXelpros (latanoprost ophthalmic solution 0.005%) is the first latanoprost product not formulated with the preservative ben…
Here are some features from the Sept. 10, 2018, issue of Ocular Surgery News: Grand Rounds at the New England Eye CenterWoman with pulmonary lesions presents with ptosisOcular motility exam revealed near complete loss of supraduction, infraduction and …
Topography-guided custom ablation treatment PRK showed good outcomes in eyes with low to moderate myopia.Forty eyes of 25 patients with low to moderate myopia, with or without astigmatism, were included in a retrospective study. They underwent topograp…
The EMA’s CHMP has recommended marketing authorization for voretigene neparvovec for inherited retinal dystrophy caused by RPE65 gene mutations in adults and children. International Approvals
DUBLIN–(BUSINESS WIRE)–The “Choroidal Neovascularization – Pipeline Review, H2 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. Choroidal Neovascularization – Pipeline Review, H2 2018, provides comprehensive information on th…
The first patient has been enrolled in a phase 1 clinical trial to evaluate the safety of a single intravitreal injection of THR-687 in the treatment of diabetic macular edema, according to a press release from Oxurion.The open-label, multicenter, dose…